Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. 097900BGGW0000048796-20231231-EN-SEP.rarPresentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2022

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 20 / 2024
Date of issue: 2024-04-01
Short name of the issuer
SOPHARMA AD
Subject
Presentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2022
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Presentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2022
Annexes
File Description
097900BGGW0000048796-20231231-EN-SEP.rar
097900BGGW0000048796-20231231-EN-SEP.rar		 Presentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2022

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-04-01 Ognian Ivanov Donev Executive Director
20240401_122426_0407934695_097900BGGW0000048796-20231231-EN-SEP.rar

Pobierz